Pharma Journalist -

Sanofi Ventures has received an additional $625 million multi-year capital commitment from its parent company, Sanofi, increasing its total assets under management to over $1.4 billion.…
Read More...

Moderna, Inc. has officially opened its Moderna Innovation and Technology Centre (MITC) at the Harwell Science and Innovation Campus in Oxfordshire, UK. This new facility will…
Read More...

Merck and Siemens have signed a new Memorandum of Understanding (MoU) to deepen their strategic partnership aimed at accelerating digital transformation across the life science industry…
Read More...

TegMine Therapeutics, a biotech company specializing in precision oncology by targeting cancer-driving glycoproteins, has announced a strategic research and development collaboration…
Read More...

Biogen Inc. announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the company’s supplemental New Drug Application (sNDA) for…
Read More...

Roche has announced positive results from the Phase III evERA study evaluating giredestrant combined with everolimus in patients with estrogen receptor (ER)-positive, HER2-negative,…
Read More...

Moderna, Inc. has announced promising preliminary immunogenicity results for the 2025-2026 formula of its COVID-19 vaccine, mNEXSPIKE, which targets the SARS-CoV-2 LP.8.1 variant. Data…
Read More...

Eli Lilly and Company announced plans to construct a $6.5 billion state-of-the-art manufacturing facility at Generation Park in Houston, Texas. This new site will focus on producing…
Read More...

Servier, the independent international pharmaceutical group, announced that the European Commission (EC) has approved VORANIGO (vorasidenib) for treating predominantly non-enhancing…
Read More...

The U.S. Food and Drug Administration (FDA) has extended the target action date for its review of Sanofi’s new drug application (NDA) for tolebrutinib by three months, now set for…
Read More...